The Sodium Bicarbonate Injection, cataloged under National Stock Number 6505-00-268-9577, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Lyphomed Inc Div of Fujisawa Usa Inc. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 3 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-268-9577 |
| Primary Part Number | NDC00469-0019-25 |
| Item Name | Sodium Bicarbonate Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Lyphomed Inc Div of Fujisawa Usa Inc |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 8.400 PERCENTAGE, W/V SODIUM BICARBONATE ACTIVE INGREDIENT |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00469-0019-25 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
| 6625-02 | Abbott Laboratories Inc. Div Hospital Products Division (USA) |
| 1950 | Invenex Laboratories Life Technologies Inc (USA) |
| NDC00074-6625-02 | Abbott Laboratories Inc. Div Hospital Products Division (USA) |
NSN 6505-00-268-9577 is a Sodium Bicarbonate Injection, manufactured by Lyphomed Inc Div of Fujisawa Usa Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-00-268-9577 has 4 cross-referenced part numbers: NDC00469-0019-25 (Lyphomed Inc Div of Fujisawa Usa Inc), 6625-02 (Abbott Laboratories Inc. Div Hospital Products Division), 1950 (Invenex Laboratories Life Technologies Inc), NDC00074-6625-02 (Abbott Laboratories Inc. Div Hospital Products Division).
There are 12 known substitutes for 6505-00-268-9577: 5365-00-057-7770, 6625-00-106-7497, 7490-00-153-9685 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00469-0019-25: Administration: INTRAVENOUS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Active Medicament Medicinal Strength: 8.400 PERCENTAGE, W/V SODIUM BICARBONATE ACTIVE INGREDIENT. 6 total characteristics are documented in the Federal Logistics Information System.